Legal & General Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
81,792
+21,386
| +35% | +$669K | ﹤0.01% | 1865 |
|
|
2025
Q1 | $2.03M | Hold |
60,406
| – | – | ﹤0.01% | 1918 |
|
|
2024
Q4 | $2.37M | Buy |
60,406
+5,286
| +10% | +$207K | ﹤0.01% | 1908 |
|
|
2024
Q3 | $2.17M | Hold |
55,120
| – | – | ﹤0.01% | 1928 |
|
|
2024
Q2 | $2.15M | Buy |
55,120
+110
| +0.2% | +$4.29K | ﹤0.01% | 1920 |
|
|
2024
Q1 | $2.37M | Buy |
55,010
+1,361
| +3% | +$58.6K | ﹤0.01% | 1869 |
|
|
2023
Q4 | $2.47M | Buy |
53,649
+8,936
| +20% | +$412K | ﹤0.01% | 1847 |
|
|
2023
Q3 | $1.53M | Buy |
44,713
+1,921
| +4% | +$65.6K | ﹤0.01% | 2016 |
|
|
2023
Q2 | $1.65M | Sell |
42,792
-4,683
| -10% | -$180K | ﹤0.01% | 2004 |
|
|
2023
Q1 | $1.7M | Buy |
47,475
+31,947
| +206% | +$1.14M | ﹤0.01% | 1948 |
|
|
2022
Q4 | $612K | Buy |
15,528
+3,950
| +34% | +$156K | ﹤0.01% | 2288 |
|
|
2022
Q3 | $418K | Buy |
11,578
+305
| +3% | +$11K | ﹤0.01% | 2390 |
|
|
2022
Q2 | $343K | Buy |
11,273
+502
| +5% | +$15.3K | ﹤0.01% | 2448 |
|
|
2022
Q1 | $330K | Buy |
10,771
+258
| +2% | +$7.91K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $328K | Buy |
10,513
+3,765
| +56% | +$117K | ﹤0.01% | 2542 |
|
|
2021
Q3 | $103K | Buy |
6,748
+5,552
| +464% | +$84.7K | ﹤0.01% | 2838 |
|
|
2021
Q2 | $22K | Hold |
1,196
| – | – | ﹤0.01% | 3268 |
|
|
2021
Q1 | $21K | Hold |
1,196
| – | – | ﹤0.01% | 3120 |
|
|
2020
Q4 | $18K | Hold |
1,196
| – | – | ﹤0.01% | 3144 |
|
|
2020
Q3 | $13K | Hold |
1,196
| – | – | ﹤0.01% | 3137 |
|
|
2020
Q2 | $15K | Buy |
+1,196
| New | +$15K | ﹤0.01% | 3194 |
|